Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Glabellar Lines”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06481475
What this trial is testing

Investigate the Safety and Efficacy of YY003 in Adults With Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 153
Post-approval studies (Phase 4)Study completedNCT03687736
What this trial is testing

Subject Satisfaction With AbobutulinumtoxinA Treatment

Who this might be right for
Glabellar Frown Lines
Galderma R&D 120
Testing effectiveness (Phase 2)Study completedNCT02236312
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 359
Large-scale testing (Phase 3)Study completedNCT05146999
What this trial is testing

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 132
Large-scale testing (Phase 3)Study completedNCT02334423
What this trial is testing

A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 330
Large-scale testing (Phase 3)Study completedNCT03216408
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Medy-Tox 504
Early research (Phase 1)Study completedNCT05292638
What this trial is testing

Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines

Who this might be right for
Glabellar Lines
CKD Bio Corporation 30
Testing effectiveness (Phase 2)Study completedNCT06246552
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Jetema USA Inc. 480
Post-approval studies (Phase 4)Study completedNCT01814670
What this trial is testing

Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines

Who this might be right for
Glabellar Rhytides
Allergan 185
Large-scale testing (Phase 3)Study completedNCT04830345
What this trial is testing

Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
EuBiologics Co.,Ltd 290
Large-scale testing (Phase 3)Study completedNCT04622254
What this trial is testing

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines

Who this might be right for
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
Merz North America, Inc. 368
Testing effectiveness (Phase 2)Study completedNCT03736928
What this trial is testing

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 401
Large-scale testing (Phase 3)Study completedNCT03837561
What this trial is testing

The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 136
Large-scale testing (Phase 3)Study completedNCT05804656
What this trial is testing

Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial

Who this might be right for
Glabellar Lines
CKD Bio Corporation 300
Large-scale testing (Phase 3)Study completedNCT06499688
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 529
Testing effectiveness (Phase 2)Study completedNCT02428608
What this trial is testing

Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 570
Large-scale testing (Phase 3)Study completedNCT05531968
What this trial is testing

Treatment of Moderate to Severe Glabellar Lines (BMI2006)

Who this might be right for
Glabellar Lines
BMI Korea 278
Large-scale testing (Phase 3)Study completedNCT04594213
What this trial is testing

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines

Who this might be right for
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
Merz North America, Inc. 362
Early research (Phase 1)Study completedNCT06151561
What this trial is testing

Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
AbbVie 24
Testing effectiveness (Phase 2)Study completedNCT04281095
What this trial is testing

A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
ATGC Co., Ltd. 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation